Treatment‐related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemiaWeili Sun, Alan S. Wayne, Jennifer J. Wilkes et al.|Pediatric Blood & Cancer|2016Cited by 29
The UK ALLR3 Chemotherapy Regimen for Relapsed/Refractory Acute Lymphoblastic Leukemia of Childhood: A Multi-Institutional Retrospective Study of Treatment Related Adverse EventsWeili Sun, Alan S. Wayne, Alison Smith et al.|Blood|2014Cited by 4